Canada needs a publicly owned facility to produce medicine and vaccines

The federal government’s failures to secure domestic production of any of the early vaccine candidates highlighted the enormous policy mistake to privatize the government-owned company, Connaught Laboratories.
A pedestrian, pictured Jan. 11, 2021, walking past a COVID-19-themed mural outside Ottawa City Hall. Last year’s desperate scramble for personal protective equipment, gloves, masks, and gowns, revealed to most people’s shock that for basic medical supplies we were dependent on the goodwill of foreign countries that have authoritarian governments.
As the COVID-19 pandemic has exposed, Canada’s economy has become more fragile and less resilient than it was, due to decades of government neglect of our domestic manufacturing sector as supply chains have been allowed to be outsourced. While many have raised these concerns for years, this public...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Tuesdays: Innovation & Industry Newsletter

The policies, decisions, and people working on investment and regulation in the industry and innovation realm.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE Opinion

RELATED STORIES